Innovating the Future of Regenerative Medicine
We are a regenerative medicine company developing innovative technologies and products for medical aesthetics, tissue regeneration, and organ manufacturing.
We use cookies to show you content that is relevant to you. By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Feel free to read more about cookies by clicking “settings”
Our Focus Areas
Regenerative Medicine
Our rhCollagen technology, combined with advanced biomaterials and biofabrication methods, like 3D bioprinting, enables the production of functional tissues and organs, opening new frontiers in personalized regenerative medicine.
Regenerative Medical
Aesthetics
We develop regenerative dermal fillers and implants with the potential to create a paradigm shift in the aesthetics market – combining cutting-edge science with natural tissue regeneration to deliver longer-lasting, biocompatible results.
Drug Discovery & Personalized Medicine
Our advanced biomaterials and high-resolution bioprinting technology provide the essential building blocks for fabricating tissue and disease models – accelerating drug discovery, enhancing predictability, and enabling personalized treatment strategies.
Regenerative Medicine
Our rhCollagen technology, combined with advanced biomaterials and biofabrication methods, like 3D bioprinting, enables the production of functional tissues and organs, opening new frontiers in personalized regenerative medicine.
Regenerative Medical
Aesthetics
We develop regenerative dermal fillers and implants with the potential to create a paradigm shift in the aesthetics market – combining cutting-edge science with natural tissue regeneration to deliver longer-lasting, biocompatible results.
Drug Discovery & Personalized Medicine
Our advanced biomaterials and high-resolution bioprinting technology provide the essential building blocks for fabricating tissue and disease models – accelerating drug discovery, enhancing predictability, and enabling personalized treatment strategies.
Our Technology
rhCollagen
CollPlant’s products are based on type I recombinant human collagen (rhCollagen), which is genetically and structurally identical to the collagen naturally produced by the human body. This makes rhCollagen an ideal building block for a wide range of regenerative medicine applications, including tissue engineering and organ manufacturing.
Bioinks for 3D Bioprinting
Collink.3D™ is a bioink platform engineered with our proprietary recombinant human collagen (rhCollagen). It is biocompatible, has a high safety profile, and features tunable rheological properties. Designed for 3D bioprinting, Collink.3D™ enables precise mimicry of the physical characteristics of human tissues and organs to support optimal tissue regeneration.
Our Products Portfolio
Collage™
(rhCollagen)
Derived from plants, and bioidentical to native human collagen, CollPlant’s rhCollagen offers a safer, purer, and more functional solution than animal-derived collagen – enhancing tissue regeneration while minimizing immune reactions.
Collink.3D™
(rhCollagen-based bioinks)
The world’s only bioink platform based on type I recombinant human collagen (rhCollagen). Produced at scale with high purity and batch-to-batch consistency, these bioinks enable reproducible biofabrication of tissue models, functional tissues, and organs.
Vergenix™STR
(Soft Tissue Repair Matrix)
Vergenix™STR is an advanced tissue repair matrix of recombinant human collagen (rhCollagen) to be combined with autologous Platelet-Rich Plasma (PRP). This product is indicated for the treatment of tendinopathy, which affects approximately 2% of the general population and is responsible for over 40% of sports-related injuries.
Our Product pipeline
Dermal Fillers
CollPlant is developing cutting-edge rhCollagen-based dermal and soft tissue fillers to promote soft tissue regeneration. Our innovative photocurable dermal and soft tissue filler combines rhCollagen with hyaluronic acid, and provides skin lifting, tissue regeneration, and contouring abilities.
Breast Implants
CollPlant’s innovative regenerative breast implants comprised of our proprietary rhCollagen and other biomaterials. Their unique properties aim to promote tissue regeneration while degrading in synchronization with the newly grown tissue, potentially presenting a significant change in the aesthetic market.
News & Events
August 24, 2023
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
August 24, 2023
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
August 24, 2023
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million